Medical Oncologist
Breast cancer in men is rare — only about 1% of all breast cancers — but it is real. Men have a small amount of breast tissue behind the nipple, and cancer can start there. The commonest first sign is a painless lump behind the nipple, and most male breast cancers are hormone-receptor-positive, so endocrine therapy plays a central role. Because men often do not expect breast cancer, it is frequently found late — which is exactly why prompt evaluation matters. At CION, a woman-headed, tumour-board-led team gives men a private, dignified, accurate plan — without rushed decisions or unnecessary tests.
Male breast cancer is cancer that starts in the small amount of breast tissue that men have behind and around the nipple. Many people assume only women can get breast cancer, but the same milk-duct and gland tissue exists in men in a much smaller quantity — and cancer can develop there. It is uncommon, making up only about 1% of all breast cancers, yet for the men affected it is every bit as important to find and treat early. The pathway to diagnosis and breast cancer treatment in men mirrors that for women, with a few important differences.
Because awareness is low, men frequently mistake the first sign — usually a painless lump beneath the nipple — for something harmless and delay seeing a doctor. The cancer is confirmed the same way it is in women: by examining tissue from a breast biopsy, including testing for the oestrogen, progesterone and HER2 receptors. The large majority of male breast cancers are hormone-receptor-positive, which directly shapes how they are treated.
Breast cancer in men is rare — roughly 1 in 100 breast cancers — but it is a real diagnosis, and men should know the warning signs just as women do.
Behind the nipple, men carry a small amount of the same duct and gland tissue found in women. Cancer can start in this tissue, which is why men are not immune.
Most male breast cancers test positive for the hormone (oestrogen) receptor, so endocrine therapy is usually a key part of the treatment plan.
Men account for only about 1% of all breast cancers, but they are far more likely to be diagnosed at a later stage than women — largely because the disease is unexpected and the early signs are ignored. Roughly 1 in 5 men with breast cancer carries an inherited BRCA2 change, so genetic testing is recommended for every man diagnosed. Source: NCCN Breast Cancer guidance; SEER; WHO.
The warning signs of breast cancer in men are similar to those in women, but they are usually easier to feel and notice because men have so little breast tissue. The single most common sign is a painless lump behind or beside the nipple. Any new, firm, persistent change in the chest, nipple or armpit should be checked promptly — most are not cancer, but the ones that are need to be found early.
If you notice any of the changes below and they do not settle within a couple of weeks, see a doctor. Don't wait to "see if it goes away" — in men, that wait is the main reason breast cancer is found late.
By far the commonest sign — a firm, usually painless lump felt right under or beside the nipple. Because men have little breast tissue, even a small lump is noticeable.
A newly pulled-in nipple (nipple retraction or inversion), or any nipple discharge — sometimes bloodstained — should always be examined.
Puckering, dimpling, redness, scaling or an ulcer (open sore) over the breast or nipple area can be a warning sign, especially when it does not heal.
Swelling or a firm lump in the armpit may mean the cancer has reached the nearby lymph nodes — another reason not to delay assessment.
The strongest known factor in male breast cancer is inherited genetics — particularly a BRCA2 mutation, and to a lesser extent BRCA1. Many of the other risk factors share a common thread: anything that tips a man's hormone balance towards higher oestrogen relative to testosterone can increase risk. Most men with breast cancer cannot point to a single cause, so having a risk factor does not mean you will get it — and not having one does not rule it out.
An inherited BRCA2 change is the single biggest risk factor for male breast cancer; BRCA1 plays a smaller role. This is why genetic testing is advised for every man diagnosed.
A father, brother or close relative with breast cancer raises risk, as does increasing age — most men are diagnosed in their 60s and 70s, though it can occur earlier.
Klinefelter syndrome, liver disease (cirrhosis), marked obesity and some hormone treatments raise the body's oestrogen levels and can increase the chance of breast cancer in men.
Radiation to the chest earlier in life — for example for another cancer — is a recognised risk factor for developing breast cancer in men years later.
The diagnostic pathway for men is the same triple-assessment used for women: a clinical examination, imaging, and a tissue sample. Because a lump in a man's chest is easy to feel, a clear answer can often be reached quickly once a man comes forward. The key step is the biopsy, which both confirms the cancer and tests the hormone and HER2 receptors that guide treatment.
The doctor examines the lump, the nipple and the armpit, and asks about family history. In men, the lump's position right behind the nipple is often a useful clue.
Imaging — a mammogram and/or an ultrasound of the breast and armpit — helps define the lump and check the lymph nodes before any tissue is taken.
A core needle biopsy removes a small sample of the lump under local anaesthetic. This is what confirms whether it is cancer.
The biopsy is tested for the oestrogen, progesterone and HER2 receptors. Most male breast cancers are hormone-receptor-positive, which steers the treatment plan towards endocrine therapy.
A rare diagnosis is exactly the situation where a single doctor's opinion is not enough. Men are welcome at CION, where care is private and dignified — and every case, common or rare, is planned by a full tumour board rather than one person. That means accurate receptor testing, BRCA-informed planning, and a treatment sequence chosen by a panel of specialists working together.
Talk to our team
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Private, dignified, tumour-board-reviewed, BRCA-informed care for men across 35+ centres in Telangana & AP. Call 1800-202-8726.
Treatment for men uses the same tools as for women, combined to fit the man and his cancer. The first step is usually surgery. Because men have so little breast tissue, breast-conserving surgery (lumpectomy) is rarely practical, so most men have a mastectomy together with a check of the underarm lymph nodes (a sentinel node biopsy). After surgery, radiation is often given, and because most male breast cancers are hormone-receptor-positive, endocrine therapy is a cornerstone of long-term treatment.
At CION, this sequence is set by the tumour board for your specific stage and receptor status — so you get the right treatment in the right order, without unnecessary tests or delay.
In India and elsewhere, men with breast cancer tend to be diagnosed at a more advanced stage than women. The reasons are not biological — they are about awareness. Most men simply do not expect breast cancer, so a lump behind the nipple is dismissed or ignored, sometimes for months. There is also embarrassment about a "women's disease", and very little public messaging aimed at men. The good news is that this is one of the most fixable problems in the whole condition: a man who acts on the first sign can often be diagnosed early, when treatment works best.
That is why this page exists. If you are a man reading this with a new lump or nipple change, the single most useful thing you can do is get it examined now rather than later.
Stage-for-stage, the outlook for men with breast cancer is broadly similar to that for women. The biggest single factor is the stage at which it is found — and because men so often present late, the average figures can look worse even though the underlying biology is comparable. In other words, the gap is largely about timing, not about men responding less well to treatment. That is the encouraging message: by acting early on a lump or nipple change, a man can give himself the same good odds that early-stage breast cancer carries in women.
Your own outlook depends on your stage, your receptor status, and how the cancer responds to treatment — not on any single average. The CION figure below is a general breast-cancer survival result for all patients treated at CION; it is not specific to men, but it reflects the value of an accurate, team-based plan.
CION breast cancer 1-year survival (all patients): 96.9% vs national average 85.4% (+11.5%). *1-year survival, all breast cancer patients (not male-specific). Source: ICMR / National Cancer Registry Programme (NCRP).
Genetic testing is not an optional extra for men with breast cancer — it is a core part of good care. Guidelines recommend offering BRCA testing to every man diagnosed with breast cancer, regardless of age or family history, because male breast cancer is so strongly linked to inherited BRCA2 changes. The result can change your follow-up, guide treatment, and protect your family's future.
At CION, genetic testing is discussed up front for men, with counselling so you understand what the result means before and after the test.
If you have found a lump or noticed a nipple change, the decisions made in the first few weeks matter. You do not have to navigate them alone. CION offers a clear, private pathway for men — from first consultation to treatment, built around your stage and receptor status — with your first consultation free.
A specialist examines you, reviews any reports in full, explains what your findings mean, and outlines the likely next steps — no rushed decisions, no unnecessary tests, and complete privacy.
We arrange a core needle biopsy with receptor (ER/PR/HER2) testing, plus BRCA testing with counselling — up to 50% discounts on diagnostics.
3+ oncologists plan your treatment together — typically mastectomy with sentinel node biopsy, then endocrine therapy with tamoxifen, radiation, and chemotherapy or HER2-targeted therapy if indicated.
Surgery, radiation, endocrine therapy and any systemic treatment as needed — with nutrition, emotional support and transparent costs throughout your care.
Hear from patients treated at CION — diagnosis, treatment path, and where they are today.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Talk to our team
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Yes. Although it is uncommon — about 1% of all breast cancers occur in men — breast cancer in men is a real diagnosis. Men have a small amount of breast tissue behind and around the nipple, made up of the same ducts and glands found in women, and cancer can develop there. Because most people assume only women are affected, men often dismiss the early signs, which is why male breast cancer is frequently found at a later stage. The single most useful thing a man can do is to treat any new lump behind the nipple, or any nipple change, as something to get examined promptly rather than ignored.
The commonest sign is a firm, usually painless lump behind or beside the nipple — easy to feel because men have so little breast tissue. Other warning signs include a newly pulled-in nipple (retraction or inversion), nipple discharge that may be bloodstained, dimpling, redness, scaling or an ulcer over the breast or nipple, and a lump in the armpit. Most of these changes are not cancer, but any new change that does not settle within a couple of weeks should be examined. In men, the main reason breast cancer is found late is waiting to "see if it goes away" — so it is best to get it checked early.
There is rarely a single cause, but several factors raise the risk. The strongest is an inherited BRCA2 gene change, and to a lesser extent BRCA1. A family history of breast cancer and increasing age also matter — most men are diagnosed in their 60s and 70s. Many other risk factors share a common thread: conditions that raise the body's oestrogen relative to testosterone, such as Klinefelter syndrome, liver disease (cirrhosis), marked obesity and some hormone treatments. Previous radiation to the chest is also a recognised risk factor. Having a risk factor does not mean you will get breast cancer, and many men who develop it have none of these.
The pathway is the same triple assessment used for women: a clinical examination, imaging, and a tissue sample. The doctor examines the lump, nipple and armpit and asks about family history. A mammogram and/or ultrasound helps define the lump and check the lymph nodes. The key step is a core needle biopsy, which removes a small sample under local anaesthetic to confirm whether it is cancer. The biopsy is also tested for the oestrogen, progesterone and HER2 receptors. Because a lump in a man's chest is easy to feel, a clear answer can often be reached quickly once a man comes forward.
Treatment uses the same tools as for women, combined to fit the man and his cancer. Surgery is usually a mastectomy — because there is little breast tissue, breast-conserving surgery is rarely practical — together with a sentinel lymph node biopsy. Radiation is often given afterwards, especially for larger or node-positive tumours. As most male breast cancers are hormone-receptor-positive, endocrine therapy is central, and tamoxifen is the mainstay for men. Chemotherapy is added for higher-risk cancers, and HER2-targeted therapy is used when the tumour is HER2-positive. At CION, the sequence is set by a tumour board for your specific stage and receptor status.
Yes — guidelines recommend offering BRCA testing to every man diagnosed with breast cancer, regardless of age or family history, because male breast cancer is so strongly linked to inherited BRCA2 changes (and, less often, BRCA1). The result matters in several ways: it can inform your treatment and follow-up, and it lets your relatives — children, siblings and parents of both sexes — consider their own testing, screening and prevention. Testing should always come with genetic counselling so you understand what the result means before and after the test. At CION, genetic testing and counselling are built into the pathway for men from the start.
Stage-for-stage, the outlook for men is broadly similar to that for women — the cancer itself is not inherently more dangerous in men. The reason average figures can look worse is timing: men often present at a later stage because the disease is unexpected and the early signs are ignored. In other words, the gap is largely about how early it is found, not about men responding less well to treatment. That is encouraging, because it means a man who acts promptly on a lump or nipple change can give himself the same good odds that early-stage breast cancer carries in women. Your own outlook depends on your stage, receptor status and treatment response.
Yes. CION offers a free first consultation for all cancer patients, including men who have found a lump, noticed a nipple change, or want a second opinion. It is a full 45-minute consultation in a private, dignified setting — a specialist examines you, reviews any reports, arranges biopsy and receptor testing if needed, discusses genetic testing with counselling, and gives you a clear, tumour-board-backed plan. There are no rushed decisions and no unnecessary tests, and CION offers up to 50% discounts on diagnostics. You can book on 1800-202-8726 or request a callback through the form on this page.
Browse our complete guide to breast cancer — types, symptoms, tests and treatments. Tap any topic to read more.